Philippines - English - FDA (Food And Drug Administration)

medilyn drug - phenylpropanolamine hydrochloride - syrup - 12.5mg/5ml

Philippines - English - FDA (Food And Drug Administration)

medilyn drug - salbutamol (as sulfate) , guaifenesin - syrup - 1mg/50mg per 5ml

Philippines - English - FDA (Food And Drug Administration)

medilyn drug - vitex negundo l. (lagundi leaf) - tablet - 600 mg

Philippines - English - FDA (Food And Drug Administration)

medilyn drug - vitex negundo l. (lagundi leaf) - syrup - 300mg/5ml

Philippines - English - FDA (Food And Drug Administration)

medilyn drug - vitex negundo l. (lagundi leaf) - tablet - 300mg

European Union - English - EMA (European Medicines Agency)

alfasigma s.p.a. - methylthioninium chloride - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

European Union - English - EMA (European Medicines Agency)

zentiva k.s. - efavirenz, emtricitabine, tenofovir disoproxil, phosphate - hiv infections - antivirals for systemic use, - efavirenz/emtricitabine/tenofovir disoproxil zentiva is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil. it is indicated for the treatment of human immunodeficiency virus-1 (hiv-1) infection in adults aged 18 years and over with virologic suppression to hiv-1 rna levels of < 50 copies/ml on their current combination antiretroviral therapy for more than three months. patients must not have experienced virological failure on any prior antiretroviral therapy and must be known not to have harboured virus strains with mutations conferring significant resistance to any of the three components contained in efavirenz/emtricitabine/tenofovir disoproxil zentiva prior to initiation of their first antiretroviral treatment regimen., the demonstration of the benefit of the combination efavirenz/emtricitabine/tenofovir disoproxil is primarily based on 48-week data from a clinical study in which patients with stable virologic suppression on a combination antiretroviral therapy changed to efavir

Philippines - English - FDA (Food And Drug Administration)

ambica international trading corp.; distributor: medilyn drug - candesartan cilexetil - tablet - 8 mg

Philippines - English - FDA (Food And Drug Administration)

gamot philippines, inc.; distributor: medilyn drug - co-amoxiclav - film-coated tablet - 500 mg/125 mg